Location: Penn State Cancer Institute
Penn State College of Medicine has been awarded a $1 million research grant from the PA Department of Health's CURE program, earmarked for the development of a cancer treatment with commercialization potential.
Penn State Hershey Medical Center, Lancaster Regional and Heart of Lancaster Regional Medical Centers have entered into an agreement that will offer Lancaster County residents expanded oncology services and expertise and increased access to the latest cancer research, keeping them close to home.
Technology developed at Penn State College of Medicine and Penn State Hershey Cancer Institute led to the recent launch of a new start-up company focused on discovering, developing, and commercializing innovative new therapies for late stage melanoma and other skin cancers.
Penn State Milton S. Hershey Medical Center this week unveiled new equipment that enhances its abilities to use radiosurgery to target brain tumors and functional disorders. The Medical Center has begun using Leksell Gamma Knife® Perfexion technology, which replaces its previous Gamma Knife system.
What is MDS or myelodysplastic syndrome? Here’s an explanation from Dr. David Claxton, professor of medicine in the Division of Hematology-Oncology at Penn State College of Medicine and Penn State Hershey Cancer Institute.
http://pennstatehershey.org/cancer David Stewart, M.D., a board-certified colorectal surgeon at Penn State Hershey Cancer Institute, Penn State Milton S. Hershey Medical Center, talks about a recent advance in surgery called single-site laparoscopy, a technique used to treat colorectal disease, including the removal of colon and rectal cancers through a single skin incision.